Page last updated: 2024-10-19

racemethionine and Parkinson Disease

racemethionine has been researched along with Parkinson Disease in 1 studies

Racemethionine: A preparation of METHIONINE that includes a mixture of D-methionine and L-methionine isomers.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Uceda, AB1
Frau, J1
Vilanova, B1
Adrover, M1

Other Studies

1 other study available for racemethionine and Parkinson Disease

ArticleYear
On the effect of methionine oxidation on the interplay between α-synuclein and synaptic-like vesicles.
    International journal of biological macromolecules, 2023, Feb-28, Volume: 229

    Topics: alpha-Synuclein; Humans; Methionine; Micelles; Parkinson Disease; Racemethionine; Synaptic Vesicles

2023